Triple Joy For European Biotechs As FDA OKs Byfavo
Acacia To Sell Rapid-Acting Sedative
Having secured FDA approval, the UK's Acacia Pharma will market Byfavo, the first new product in the sedation space in decades, which was licensed from Italy's Cosmo and developed by Germany's Paion.
